Neuropsychopharmacology
- UNRAVELing the synergistic effects of psilocybin and environment on brain-wide immediate early gene expression in mice3 years ago
- How should we design future mechanistic and/or efficacy clinical trials?3 years ago
- Region- and time- specific effects of ketamine on cerebral blood flow: a randomized controlled trial3 years ago
- Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants3 years ago
- Dopamine D2 receptors in nucleus accumbens cholinergic interneurons increase impulsive choice3 years ago
- Involvement of cortical input to the rostromedial tegmental nucleus in aversion to foot shock3 years ago
- Accelerated TMS – moving quickly into the future of depression treatment3 years ago
Journal of Psychopharmacology
- Serotonin type 5A receptor antagonists inhibit D-lysergic acid diethylamide discriminatory cue in rats7 years ago
- Memory impairment following intentional self-poisoning with benzodiazepines: Should we pay more attention to attention?7 years ago
- Transient receptor potential vanilloid 1 mediates cocaine reinstatement via the D1 dopamine receptor in the nucleus accumbens7 years ago
- Characteristics of deaths associated with kratom use7 years ago
- Evaluation of agomelatine for the treatment of sleep problems in adults with autism spectrum disorder and co-morbid intellectual disability7 years ago
- Developing a phone-based measure of impairment after acute oral ∆9-tetrahydrocannabinol7 years ago
- Clozapine and tardive dyskinesia in patients with schizophrenia: A systematic review7 years ago
European Neuropsychopharmacology
- P.849A five-year follow up study of a naturalistic cohort treated with long-acting injectable antipsychotics6 years ago
- P.820Pharmacological inhibition of soluble epoxide hydrolase protects cognitive impairment in a Niemann-Pick mice model6 years ago
- P.850Real-world effectiveness of aripiprazole long-acting injectable6 years ago
- P.824Positive and negative symptoms, cognitive deficits and antipsychotic treatment in schizophrenic patients6 years ago
- P.851Differences in healthcare resource utilization across oral atypical antipsychotic treatments in patients with schizophrenia6 years ago
- P.829Clinical characteristics of schizophrenia offspring, children diagnosed with attention deficit hiperactivity disorder and healthy controls6 years ago
- P.855Efficacy and safety of lurasidone in adolescents and young adults with schizophrenia: pooled analysis of double-blind, placebo-controlled 6-week studies6 years ago